Uya has 15 years of healthcare experience across a range of functions including venture capital, public equity investing, technology transfer and academic research. Prior to joining Avoro Ventures in March 2022, Uya was a Principal at Amzak Health where she led private and public biotech investments. During her time at Amzak, Uya was involved in 13 venture investments resulting in 5 IPOs and 2 acquisitions. Prior to Amzak, Uya was a sell-side biotech equity research analyst at Goldman Sachs covering large and mid-cap companies. Uya completed her Ph.D. in Microbiology at New York University School of Medicine, conducting research in virus-host interactions and viral protein synthesis. Her work was published in several scientific, peer-reviewed journals. She holds a B.S. in Biochemistry from Cornell University.
+1 212.937.4970